Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antibody-drug conjugates
Biotech
Pyxis' shares fall on lukewarm early ADC results in solid tumors
While one might expect a positive readout from a biotech’s lead asset to boost stock prices, Pyxis Oncology’s shares tell a different story.
Fraiser Kansteiner
Nov 21, 2024 2:30pm
NextCure stops programs to take ADC fight to Big Pharma trio
Nov 8, 2024 6:16am
ADC Therapeutics axes lead solid tumor drug after phase 1 blow
Nov 7, 2024 8:24am
MacroGenics pauses work on ADC pending mature survival data
Nov 6, 2024 4:44am
Ono inks $700M biobuck deal to bag preclinical LigaChem ADC
Oct 10, 2024 9:40am
AstraZeneca, Daiichi ADC fails to improve breast cancer survival
Sep 23, 2024 7:23am
